Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose Escalation Tolerance and Pharmacokinetics Study of AL8326 in Advanced Solid Tumor

NCT04890587 is registered in ClinicalTrials.gov with Advenchen Laboratories Nanjing Ltd. as lead sponsor.

NCT NCT04890587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04890587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose Escalation Tolerance and Pharmacokinetics Study of AL8326 in Advanced Solid Tumor
Lead sponsor
Advenchen Laboratories Nanjing Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
August 17, 2017
Completion date
December 31, 2023
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors